Pelvital, a Minneapolis-based medical device company, announced Tuesday that Ryan Willemsen has been appointed Chief Operations Officer.
Willemsen joins Pelvital following a 14-year career at Medtronic, where he held executive leadership positions in marketing, strategy, business development and finance.
“We are excited to have Ryan expanding his influence in developing and growing Pelvital," said Dale Wahlstrom Co-Founder and CEO of Pelvital. "His proven track record of executive leadership will not only help us develop the market for Flyte but will help us prepare the company for expansion into other applications of our unique mechanotherapy technology."
As COO, Willemsen will focus on the market adoption of Flyte, an FDA-cleared non-surgical treatment for female stress urinary incontinence (SUI). His responsibilities will also include building a global sales and distribution network, expanding the company's operational infrastructure and bringing more products to the market.
“I am very excited to be part of the Pelvital team and thrilled to be part of bringing a proven new technology platform to the market,” said Willemsen. “The clinical data, and the response of patients who have used the product since our market release in January, have confirmed that mechanotherapy really works to treat SUI."
